Vorasidenib
CAS 1644545-52-7Small Molecule
Overview
Vorasidenib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4279047).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Vorasidenib expires 16 Jan 2039 and exclusivity 6 Aug 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 6-(6-chloro-2-pyridinyl)-2-N,4-N-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine
- Canonical SMILES
- C[C@H](C(F)(F)F)NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)N[C@H](C)C(F)(F)F
- InChIKey
- QCZAWDGAVJMPTA-RNFRBKRXSA-N
Verified Supplier Partner
Do you supply Vorasidenib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.